STAT October 17, 2024
Why are biotech investors so interested in autoimmune disease? Who is behind the telehealth GLP-1 boom? And what were our favorite moments from the STAT Summit this week?
We talk about all that and more on this week’s episode of “The Readout LOUD,”...